Pharmaceutical News

RSS

Bisphosphonates appear to reduce risk of postmenopausal colorectal cancer by 50%

An international team of researchers has found that the use of bisphosphonates - drugs already taken by millions of healthy women to prevent bone-loss - for more than one year was associated with a 50 percent reduction in the risk of postmenopausal colorectal cancer. The results were published this week in the Journal of Clinical Oncology.

15 Feb 2011

RPCI offers first FDA-approved cancer treatment vaccine

The nation's first FDA-approved cancer treatment vaccine, Provenge, is being offered for the first time in Western New York at Roswell Park Cancer Institute.

15 Feb 2011

2007 financial crisis linked to increase in patients seeking treatment for prescription drug and painkiller addiction

The 2007 onset of the financial crisis that upended the U.S. economy and impacted global markets correlated closely with unprecedented numbers of patients seeking treatment for prescription drug addiction and painkiller abuse, according to leading rehabilitation center Cliffside Malibu. The Cliffside Index, the percentage of patients admitted for treatment related to those medications, rose over 60 percent between 2007 and 2008, and has continued to increase each year.

15 Feb 2011

FDA requests $4.3 billion to protect and promote health of Americans as part of FY 2012 budget

The U.S. Food and Drug Administration is requesting a budget of $4.3 billion to protect and promote the public health as part of the President's fiscal year 2012 budget — a 33 percent increase over the FDA enacted budget for FY 2010. The FY 2012 request covers the period of Oct. 1, 2011, through Sept. 30, 2012.

15 Feb 2011

Study finds GI bleeding rare outside of ICU, regardless of whether or not patients receive medication

Over the last several decades, the prophylactic use of acid-suppressive medications to help prevent gastrointestinal bleeding in hospitalized patients has increased significantly, with some studies estimating that as many as 40 to 70 percent of all medical inpatients are given these drugs at some point during their hospitalization.

15 Feb 2011

PCMA releases statement on President Obama's budget proposal for biotech medications

Pharmaceutical Care Management Association President and CEO Mark Merritt released the following statement on President Obama's budget proposal that would grant brand-name drug manufacturers seven years of market exclusivity before generic versions of biologic products can enter the market, instead of the 12 years that was passed in the health reform bill.

15 Feb 2011

Study shows lower success rate of FDA drug approval from 2003 to 2010

Biotechnology Industry Organization Industry Analysis and BioMedTracker announced results of a study today that shows the overall success rate for drugs moving through clinical trials to FDA approval from late 2003 to the end of 2010 is near one in 10. Previous reports, taken from earlier years, showed the rate of drug approvals is one in five to one in six.

15 Feb 2011

Ecstasy users show no signs of cognitive impairment: New study

The drug known as ecstasy has been used by 12 million people in the United States alone and millions more worldwide. Past research has suggested that ecstasy users perform worse than nonusers on some tests of mental ability. But there are concerns that the methods used to conduct that research were flawed, and the experiments overstated the cognitive differences between ecstasy users and nonusers.

15 Feb 2011

Apricus Bio awards Neopharm exclusive rights to market and sell Vitaros in Israel and Palestinian Territories

Apricus Biosciences, Inc., announced today that it has entered into a licensing agreement granting Neopharm Group the exclusive rights to market and sell Vitaros®, Apricus Bio's treatment for erectile dysfunction ("ED") and, when and if available, its formulation for the treatment of premature ejaculation ("PE"), in Israel and the Palestinian Territories of the Gaza Strip and the West Bank.

15 Feb 2011

Dabigatran drug helps prevent blood clots in patients with atrial fibrillation

The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association and the Heart Rhythm Society.

15 Feb 2011

State court jury rules in favor of Merck in FOSAMAX trial

Merck & Co., Inc. today said a state court jury in New Jersey found in its favor in the Rosenberg v. Merck case, rejecting the claims of a woman who blamed her dental and jaw related problems on her FOSAMAX use.

15 Feb 2011

Oral bisphosphonates outweigh the risk associated with jaw disease

A commonly prescribed osteoporosis drug is associated with a slightly elevated risk of developing the rare, but serious condition, osteonecrosis of the jaw; nonetheless the risk remains extremely low. These findings are published online in the Journal of Dental Research, the official journal of the International and American Associations for Dental Research.

14 Feb 2011

AP: Crooks find Medicare Part D an easy target

Crooks are taking advantage of lax oversight in Medicare's Part D prescription drug program to obtain highly addictive drugs including oxycodone, Ritalin, and methadone, according to results of a federal probe.

14 Feb 2011

Huntington Insurance adds HealthWarehouse.com to prescription drug benefit program

HealthWarehouse.com, Inc., a leading retail mail-order pharmacy, and Huntington Insurance, a wholly-owned subsidiary of Huntington Bancshares Incorporated and leader in employee benefits products, announced today a partnership that will give customers across the Midwest access to low-cost generic prescription medication.

14 Feb 2011

FDA accepts King's ACUROX NDA for filing with Priority review classification

Acura Pharmaceuticals, Inc. today announced that it has been informed by King Pharmaceuticals Research and Development Inc. (King) that King's New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets was accepted for filing by the US Food and Drug Administration (FDA) with a Priority review classification and a Prescription Drug User Fee Act (PDUFA) date of June 17, 2011.

14 Feb 2011

Study: Young survivors covered by Medicare Part D often can't afford stroke medications

Young, uninsured stroke survivors or those covered by the Medicare Part D drug benefit often can't afford medications - increasing the risk for future strokes or other cardiovascular disease-related events, according to research presented at the American Stroke Association's International Stroke Conference 2011.

14 Feb 2011

UH Case Stroke and Cerebrovascular Center increases tPA use for ischemic stroke by 13.5 times

University Hospitals Stroke and Cerebrovascular Center recently reported that it has increased the use of tPA or "clot busting therapy" for ischemic stroke by 13.5 times throughout UH system hospitals since implementing the System Stroke Program. Launched in 2008, SSP sought to increase access to the lifesaving treatment for acute ischemic stroke patients in the 15 counties surrounding Cleveland.

14 Feb 2011

Janssen, Medivir collaborate to discover and develop drugs against dengue virus

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, announces today that it has signed a collaboration agreement with Janssen Pharmaceutica N.V. for the discovery and development of drugs for the prophylaxis and treatment of dengue virus infection.

14 Feb 2011

Advocates call for follow-through on decade-old pledge to remove tariffs on malaria treatments, prophylactics in Africa

"Malaria prevention advocates say many lives can be saved by removing taxes and tariffs from essential commodities used to fight the disease," VOA News reports. A decade ago, African leaders promised to remove tariffs on products used to fight malaria, but only six countries have actually done so, according to the Malaria Taxes and Tariffs Advocacy Project, which held a meeting in Geneva on Wednesday, Reuters reports.

14 Feb 2011

Antimicrobial CPC non alcohol mouth-rinse decreases incidence of preterm birth

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that use of non alcohol antibacterial mouth-rinse containing cetylpyridinium chloride decreases the incidence of preterm birth.

14 Feb 2011

Pharmaceutical News

Bisphosphonates appear to reduce risk of postmenopausal colorectal cancer by 50%

RPCI offers first FDA-approved cancer treatment vaccine

2007 financial crisis linked to increase in patients seeking treatment for prescription drug and painkiller addiction

FDA requests $4.3 billion to protect and promote health of Americans as part of FY 2012 budget

Study finds GI bleeding rare outside of ICU, regardless of whether or not patients receive medication

PCMA releases statement on President Obama's budget proposal for biotech medications

Study shows lower success rate of FDA drug approval from 2003 to 2010

Ecstasy users show no signs of cognitive impairment: New study

Apricus Bio awards Neopharm exclusive rights to market and sell Vitaros in Israel and Palestinian Territories

Dabigatran drug helps prevent blood clots in patients with atrial fibrillation

State court jury rules in favor of Merck in FOSAMAX trial

Oral bisphosphonates outweigh the risk associated with jaw disease

AP: Crooks find Medicare Part D an easy target

Huntington Insurance adds HealthWarehouse.com to prescription drug benefit program

FDA accepts King's ACUROX NDA for filing with Priority review classification

Study: Young survivors covered by Medicare Part D often can't afford stroke medications

UH Case Stroke and Cerebrovascular Center increases tPA use for ischemic stroke by 13.5 times

Janssen, Medivir collaborate to discover and develop drugs against dengue virus

Advocates call for follow-through on decade-old pledge to remove tariffs on malaria treatments, prophylactics in Africa

Antimicrobial CPC non alcohol mouth-rinse decreases incidence of preterm birth

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News